Cellular Biomedicine Group, Inc. , a biomedicine firm engaged in the development of effective treatments for degenerative and cancerous diseases, is pleased to announce today that options to purchase an aggregate of 1,000,000 shares of the Company's common stock have been exercised at an exercise price of $8.00 per share, bringing an aggregate of $8,000,000 in exercise proceeds to the Company. The Options were originally issued on July 2, 2014 to investor Francis Leung Pak To, a veteran Hong Kong investment banker.
http://ift.tt/1E7jr0g
http://ift.tt/1E7jr0g
No comments:
Post a Comment